Drug Profile
Hepatitis C immune globulin - Virionics
Alternative Names: CIgVaxLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Virionics
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-C in USA
- 24 Aug 2005 Preclinical trials in Hepatitis C in USA (unspecified route)